Status
155%
finanziert
Teilen
Finanzierungsdaten (05/11/2020)
Finanziert
GBP
415.710,00
Finanzierungsschwelle
GBP
267.000,00
Einzelheiten
Land
Großbritannien
Typologie
EigenkapitalSpain
Endtermin
05/11/2020
(1262 Tage)
Investoren
650
Beschreibung
“Focusing on a $651m market, growing due to increased life expectancy and diseases related to ageing, REGEMAT 3D develops biofabrication devices to create tissues and organs, accelerating research in the laboratory. With 2019 sales of c. €682,9k, their devices are now being used in >25 countries.”